Effects of oral administration of the competitive N-methyl-D-aspartate antagonist, CGP 40116, on passive avoidance, spatial learning, and neuromotor abilities in mice

Brain Research Bulletin

Volumn 48, Issue 3, 1999, Pages 333-341

  Hauben, Udi ^a   D'Hooge, Rudi ^a   Soetens, Eric ^b   De Deyn, Peter P ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

CGP 40116; Competitive NMDA antagonist; Neuromotor performance; Oral administration; Passive avoidance; Spatial learning

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; LEARNING; LONG TERM MEMORY; MALE; MAZE TEST; MOTONEURON; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PASSIVE AVOIDANCE; PRIORITY JOURNAL; SWIMMING; TASK PERFORMANCE;

2-AMINO-5-PHOSPHONOVALERATE; ADMINISTRATION, ORAL; ANIMALS; AVOIDANCE LEARNING; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; MUSCULOSKELETAL EQUILIBRIUM; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0032902868     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(99)00008-8     Document Type: Article

References (51)

1. Bane A., Rojas D., Indermaur K., Bennett T., Avery D. Adverse effects of dextromethorphan on the spatial learning of rats in the Morris water maze. Eur. J. Pharmacol. 302:1996;7-12.
2. Boast C.A., Pastor G., Gerhardt S.C., Hall N.R., Liebman J.M. Behavioral tolerance and sensitization to CGS 19755, a competitive N-methyl-D-aspartate receptor antagonist. J. Pharmacol. Exp. Ther. 247:1988;556-561.
3. Brandeis R., Brandys Y., Yehuda S. The use of the Morris water maze in the study of memory and learning. Int. J. Neurosci. 48:1989;29-69.
4. Butcher S.P., Davis S., Morris R.G. A dose-related impairment of spatial learning by the NMDA receptor antagonist, 2-amino-5-phosphonovalerate (AP5). Eur. Neuropsychopharmacol. 1:1990;15-20.
5. Butelman E.R. A novel NMDA antagonist, MK-801, impairs performance in a hippocampal-dependent spatial learning task. Pharmacol. Biochem. Behav. 34:1989;13-16.
6. Cain D.P., Saucier D., Boon F. Testing hypotheses of spatial learning the role of NMDA receptors and NMDA-mediated long-term potentiation . Behav. Brain Res. 84:1997;179-193.
7. Chapman A.G. Excitatory amino acid antagonists and therapy of epilepsy. Meldrum B. Excitatory amino acid antagonists. 1991;265-286 Blackwell Scientific Publications UK, Oxford.
8. Collingridge, G. L.; Watkins, J. C., eds. The NMDA receptor, 2nd ed. Oxford: Oxford University Press; 1994.
9. Cotman C.W., Iversen L.L. Excitatory amino acids in the brain - Focus on NMDA receptors. Trends Neurosci. 10:1987;288-293.
10. Crawley J., Goodwin F.K. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol. Biochem. Behav. 13:1980;167-170.
11. Danysz W., Wroblewski J.T., Costa E. Learning impairment in rats by N-methyl-D-aspartate receptor antagonists. Neuropharmacology. 27:1988;653-656.
12. Davis S., Butcher S.P., Morris R.G. The NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro. J. Neurosci. 12:1992;21-34.
13. D'Hooge R., Raes A., Van Bogaert P.P., Geelhand M., De Deyn P.P. Selective block of N-methyl-D-aspartic acid (NMDA)-evoked whole-cell currents in mouse cultured spinal neurones by CGP 40116. Br. J. Pharmacol. 120:1997;211-214.
14. D'Hooge R., Raes A., Hiramatsu M., Mori A., Van Bogaert P.-P., De Deyn P.P. Effects of competitive N-methyl-D-aspartate antagonist CGP37849 and its ethylester CGP39551 on N-methyl-D-aspartate-evoked whole-cell currents in cultured spinal neurones and on vestibular stimulation-induced seizures in EL mice. Arzneim.-Forsch./Drug Res. 48:1998;1121-1125.
15. Dunham N.W., Miya T.S. A note on a simple apparatus for detecting neurological deficit in rats and mice. J. Am. Pharm. Assoc. 46:1957;208-209.
16. Fagg G.E., Olpe H.R., Pozza M.F., Baud J., Steinmann M., Schmutz M., Portet C., Baumann P., Thedinga K., Bittiger H., Allgeier H., Heckendorn R., Angst C., Brundish D., Dingwall J.G. CGP 37849 and CGP 39551 Novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity . Br. J. Pharmacol. 99:1990;791-797.
17. Folbergrová J. Anticonvulsant action of both NMDA and Non-NMDA receptor antagonists against seizures induced by homocysteine in immature rats. Exp. Neurol. 145:1997;442-450.
18. Fujikawa D.G., Daniels A.H., Kim J.S. The competitive NMDA receptor antagonist CGP 40116 protects against status epilepticus-induced neuronal damage. Epilepsy Res. 17:1994;207-219.
19. 2+ channel blockade and the antielectroshock activity of NMDA receptor antagonists, CGP 40116 and CGP 43487, in mice. Eur. J. Pharmacol. 312:1996;27-33.
20. Goddard G.V. A step nearer the neural substrate. Nature. 319:1986;721-722.
21. Gutnikov S.A., Gaffan D. Systemic NMDA receptor antagonist CGP-40116 does not impair memory acquisition but protects against NMDA neurotoxicity in rhesus monkeys. J. Neurosci. 16:1996;4041-4045.
22. Keith J.R., Rudy J.W. Why NMDA-receptor-dependent long-term potentiation may not be a mechanism of learning and memory Reappraisal of the NMDA-receptor blockade strategy . Psychobiology. 18:1990;251-257.
23. Lederer R., Radeke E., Mondadori C. Facilitation of social learning by treatment with an NMDA receptor antagonist. Behav. Neural Biol. 60:1993;220-224.
24. Löscher W., Hönack C. High doses of memantine induce seizures in kindled but not in non-kindled rats. Naunyn Schmiedeberg's Arch. Pharmacol. 341:1990;476-481.
25. Löscher W., Hönack C. Anticonvulsant and behavioural effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP37849 and CGP39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine. J. Pharmacol. Exp. Ther. 256:1991;432-440.
26. Lu Y., France C.P., Woods J.H. Tolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons Cross-tolerance between PCP-like compounds and competitive NMDA antagonists . J. Pharmacol. Exp. Ther. 263:1992;499-504.
27. Maier C.M., Sun G.H., Kunis D.M., Giffard R.G., Steinberg G.K. Neuroprotection by the N-methyl-D-aspartate receptor antagonist CGP 40116 In vivo and in vitro studies . J. Neurochem. 65:1995;652-659.
28. Malenfant S.A., O'Hearn S., Fleming A.S. MK801, an NMDA antagonist, blocks acquisition of a spatial task but does not block maternal experience effects. Physiol. Behav. 49:1991;1129-1137.
29. Monaghan D.T., Olverman H.J., Nguyen L., Watkins J.C., Cotman C.W. Two classes of N-methyl-D-aspartate recognition sites differential distribution and differential regulation by glycine . Proc. Natl. Acad. Sci. USA. 85:1988;9836-9840.
30. Mondadori C., Weiskrantz L., Buerki H., Petschke F., Fagg G.E. NMDA receptor antagonists can enhance or impair learning performance in animals. Exp. Brain Res. 75:1989;449-456.
31. Mondadori C., Weiskrantz L. Memory facilitation induced by N-methyl-D-aspartate blockade. Baudry M., Davis J.L. Long term potentiation A debate of current issues . 1991;259-266 MIT Press, Cambridge.
32. Mondadori C., Weiskrantz L. NMDA receptor blockers facilitate and impair learning via different mechanisms. Behav. Neural Biol. 60:1993;205-210.
33. Mondadori C., Borkowski J., Gentsch C. The memory-facilitating effects of the competitive NMDA-receptor antagonist CGP 37849 are steroid-sensitive, whereas its memory-impairing effects are not. Psychopharmacology (Berl.). 124:1996;380-383.
34. Morris R.G., Garrud P., Rawlins J.N., O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature. 297:1982;681-683.
35. Morris R.G., Anderson E., Lynch G.S., Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature. 319:1986;774-776.
36. Morris R.G. Synaptic plasticity and learning selective impairment of learning rats and blockade of long-term potentiation in vivo by the N-methyl-D-aspartate receptor antagonist AP5 . J. Neurosci. 9:1989;3040-3057.
37. Morris R.G., Davis M. The role of NMDA receptors in learning and memory. Collingridge G.L., Watkins J.C. The NMDA receptor. 2nd ed. 1994;340-376 Oxford University Press, Oxford.
38. Nellgård B., Wieloch T. Cerebral protection by AMPA- and NMDA-receptor antagonists administered after severe insulin-induced hypoglycemia. Exp. Brain Res. 92:1992;259-266.
39. Nellgård B., Wieloch T. NMDA-receptor blockers but not NBQX, an AMPA-receptor antagonist, inhibit spreading depression in the rat brain. Acta Physiol. Scand. 146:1992;497-503.
40. Nellgård B., Wieloch T. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia. J. Cereb. Blood Flow Metab. 12:1992;2-11.
41. Okada M., Fujimura Y., Ueda H., Kometani M., Nakao K., Inukai T. Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on ischemic brain damage induced by four-vessel occlusion in rats. Arzneim.-Forsch./Drug Res. 47:1997;115-119.
42. Papp M., Moryl E. Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression. Eur. J. Pharmacol. 263:1994;1-7.
43. Pozza M.F., Olpe H.R., Brugger F., Fagg G.E. Electrophysiological characterization of a novel potent and orally active NMDA receptor antagonist CGP 37849 and its ethylester CGP 39551 . Eur. J. Pharmacol. 182:1990;91-100.
44. Rabbani M., Wright E.J., Little H.J. Tolerance to competitive NMDA antagonists, but no crosstolerance with barbiturates. Pharmacol. Biochem. Behav. 50:1995;9-15.
45. Sauer D., Allegrini P.R., Cosenti A., Pataki A., Amacker H., Fagg G.E. Characterization of the cerebroprotective efficacy of the competitive NMDA receptor antagonist CGP 40116 in a rat model of focal cerebral ischemia an in vivo magnetic resonance imaging study . J. Cereb. Blood Flow Metab. 13:1993;595-602.
46. Sauer D., Allegrini P.R., Fagg G.E. The competitive NMDA receptor antagonist CGP 40116 is a potent neuroprotectant in a rat model of focal cerebral ischemia. J. Neural Transm. Suppl. 43:1994;81-89.
47. Schmutz M., Portet C.H., Jeker A., Klebs K., Vassout A., Allgeier H., Heckendorn R., Fagg G.E., Olpe H.-R., van Riezen H. The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents. Naunyn Schmiedebergs Arch. Pharmacol. 342:1990;61-66.
48. Starr M.S., Starr B.S. The new competitive NMDA receptor antagonist CGP 40116 inhibits pilocarpine-induced limbic motor seizures and unconditioned motor behaviour in the mouse. Pharmacol. Biochem. Behav. 47:1994;127-131.
49. Tricklebank M.D., Singh L., Oles R.J., Preston C., Iversen S.D. The behavioural effects of MK-801 A comparison with antagonists acting non-competitively and competitively at the NMDA receptor . Eur. J. Pharmacol. 167:1989;127-135.
50. Venable N., Kelly P.H. Effects of NMDA receptor antagonists on passive avoidance learning and retrieval in rats and mice. Psychopharmacology (Berl.). 100:1990;215-221.
51. Ylinen A., Pitkanen M., Sirvio J., Hartikainen T., Sivenius J., Koivisto E., Riekkinen P.J. The effects of NMDA receptor antagonists at anticonvulsive doses on the performance of rats in the water maze task. Eur. J. Pharmacol. 274:1995;159-165.